953 related articles for article (PubMed ID: 1657460)
1. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
Verhelst JA; Trainer PJ; Howlett TA; Perry L; Rees LH; Grossman AB; Wass JA; Besser GM
Clin Endocrinol (Oxf); 1991 Aug; 35(2):169-78. PubMed ID: 1657460
[TBL] [Abstract][Full Text] [Related]
2. Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome.
Cuneo RC; Lee W; Harper J; Mitchell K; Ward G; Atkinson RL; Salkield I; Cameron DP
Clin Endocrinol (Oxf); 1997 May; 46(5):607-18. PubMed ID: 9231057
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients.
Daniel E; Aylwin S; Mustafa O; Ball S; Munir A; Boelaert K; Chortis V; Cuthbertson DJ; Daousi C; Rajeev SP; Davis J; Cheer K; Drake W; Gunganah K; Grossman A; Gurnell M; Powlson AS; Karavitaki N; Huguet I; Kearney T; Mohit K; Meeran K; Hill N; Rees A; Lansdown AJ; Trainer PJ; Minder AE; Newell-Price J
J Clin Endocrinol Metab; 2015 Nov; 100(11):4146-54. PubMed ID: 26353009
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing's syndrome by clinical features, biochemical tests and radiological findings.
Blunt SB; Sandler LM; Burrin JM; Joplin GF
Q J Med; 1990 Nov; 77(283):1113-33. PubMed ID: 2177207
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma 19-hydroxyandrostenedione levels in Cushing's disease: stimulation with ACTH and inhibition with metyrapone.
Mune T; Morita H; Yasuda K; Murayama M; Yamakita N; Miura K
Clin Endocrinol (Oxf); 1993 Mar; 38(3):265-72. PubMed ID: 8384536
[TBL] [Abstract][Full Text] [Related]
6. Different therapeutic efficacy of ketoconazole in patients with Cushing's syndrome.
Engelhardt D; Jacob K; Doerr HG
Klin Wochenschr; 1989 Feb; 67(4):241-7. PubMed ID: 2538676
[TBL] [Abstract][Full Text] [Related]
7. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease.
Colombo P; Dall'Asta C; Barbetta L; Re T; Passini E; Faglia G; Ambrosi B
Eur J Endocrinol; 2000 Aug; 143(2):227-34. PubMed ID: 10913942
[TBL] [Abstract][Full Text] [Related]
9. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease.
van Aken MO; de Herder WW; van der Lely AJ; de Jong FH; Lamberts SW
Clin Endocrinol (Oxf); 1997 Aug; 47(2):145-9. PubMed ID: 9302385
[TBL] [Abstract][Full Text] [Related]
10. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
[TBL] [Abstract][Full Text] [Related]
11. Aminoglutethimide and metyrapone in the management of Cushing's syndrome.
Thorén M; Adamson U; Sjöberg HE
Acta Endocrinol (Copenh); 1985 Aug; 109(4):451-7. PubMed ID: 3898689
[TBL] [Abstract][Full Text] [Related]
12. ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone.
Close CF; Mann MC; Watts JF; Taylor KG
Clin Endocrinol (Oxf); 1993 Sep; 39(3):375-9. PubMed ID: 8222300
[TBL] [Abstract][Full Text] [Related]
13. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
Colombo P; Passini E; Re T; Faglia G; Ambrosi B
Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the overnight and the standard metyrapone test for the differential diagnosis of adrenocorticotrophin-dependent Cushing's syndrome.
Avgerinos PC; Nieman LK; Oldfield EH; Cutler GB
Clin Endocrinol (Oxf); 1996 Oct; 45(4):483-91. PubMed ID: 8959090
[TBL] [Abstract][Full Text] [Related]
15. Subclinical Cushing's syndrome in adrenal incidentaloma.
Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
[TBL] [Abstract][Full Text] [Related]
16. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
[TBL] [Abstract][Full Text] [Related]
17. The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome.
Terzolo M; Reimondo G; Alì A; Borretta G; Cesario F; Pia A; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 2001 May; 54(5):609-16. PubMed ID: 11380491
[TBL] [Abstract][Full Text] [Related]
18. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
al-Saadi N; Diederich S; Oelkers W
Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of adrenal androgen and cortisol secretion in Cushing's syndrome.
Cunningham SK; McKenna TJ
Clin Endocrinol (Oxf); 1994 Dec; 41(6):795-800. PubMed ID: 7889616
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Aron DC; Raff H; Findling JW
J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
